Cargando…
Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story
Immune checkpoint inhibitors represent one of the most significant recent advances in clinical oncology, since they dramatically improved the prognosis of deadly cancers such as melanomas and lung cancer. Treatment with these drugs may be complicated by the occurrence of clinically-relevant adverse...
Autores principales: | Cataldi, Mauro, Manco, Federica, Tarantino, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657798/ https://www.ncbi.nlm.nih.gov/pubmed/34884762 http://dx.doi.org/10.3390/ijms222312947 |
Ejemplares similares
-
New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants
por: Cataldi, Mauro, et al.
Publicado: (2021) -
Steatosis and Steatohepatitis: Complex Disorders
por: Bettermann, Kira, et al.
Publicado: (2014) -
Heat shock protein 60 and cardiovascular diseases: An intricate love‐hate story
por: Krishnan‐Sivadoss, Indumathi, et al.
Publicado: (2020) -
Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019) -
Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?
por: Tarantino, Giovanni, et al.
Publicado: (2021)